Effect of retinol on radiation- and estrogen-induced neoplastic transformation of human breast epithelial cells

Oncology Reports

Volumn 13, Issue 6, 2005, Pages 1017-1027

  Calaf, Gloria M ^a,b   Emenaker, N J ^a   Hei, T K ^a  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSIDAD DE TARAPACÁ   (Chile)

Author keywords

Breast epithelial cells; Estrogen; Neoplastic transformation; Retinol

Indexed keywords

CYCLINE; ESTRADIOL; HYDROGEN PEROXIDE; PROTEIN C FOS; PROTEIN P53; RETINOBLASTOMA PROTEIN; RETINOL; TRANSCRIPTION FACTOR FRA 1;

ANIMAL; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL CULTURE; CELL PROLIFERATION; CELL TRANSFORMATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; HUMAN; LINEAR ENERGY TRANSFER; METABOLISM; MOUSE; MUTATION; NUDE MOUSE; PATHOLOGY; RADIATION EXPOSURE;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPITHELIAL CELLS; ESTRADIOL; HUMANS; HYDROGEN PEROXIDE; LINEAR ENERGY TRANSFER; MICE; MICE, NUDE; MUTATION; NEOPLASM INVASIVENESS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-FOS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN A;

EID: 24744459302     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.6.1017     Document Type: Article

References (44)

1. Loeb LA: Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51: 3075-3079, 1991.
2. Ames BN, Shigenaga MK and Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922, 1993. (Pubitemid 23260825)
3. Gerster H: Anticarcinogenic effect of common carotenoids. Int J Vitam Nutr Res 63: 93-121, 1993.
4. Van Poppel G: Carotenoids and cancer: an update with emphasis on human intervention studies. Eur J Cancer 29: 1335-1344, 1993.
5. Moon RC: Vitamin A, retinoids and breast cancer. Adv Exp Med Biol 364: 101-107, 1994.
6. Moon RC, Kelloff GJ, Detrisac CJ, Steele VE, Thomas CF and Sigman CC: Chemoprevention of OH-BBN-induced bladder cancer in mice by oltipraz, alone and in combination with 4-HPR and DFMO. Anticancer Res 14: 5-11, 1994. (Pubitemid 24132081)
7. Athar M, Lloyd R, Bickers DR and Mukhtar H: Malignant conversion of UV radiation- and chemically induced mouse skin benign tumors by free radical-generating compounds. Carcinogenesis 10: 1841-1845, 1989. (Pubitemid 19244858)
8. Waseem NH and Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96: 121-129, 1990.
9. Bravo R, Frank R, Blundell PA and McDonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326: 515-517, 1987. (Pubitemid 17055498)
10. Hall PA, Levison DA, Woods AL, et al: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-294, 1990.
11. Woods AL, Hall PA, Shepherd AM, Hanby AM, Waseem NH, Lane DP and Levison DA: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology 9: 21-27, 1991.
12. Calaf G, Alvarado ME and Russo J: Influence of lobular development on breast epithelial cell proliferation and steroid hormone receptor. Int J Oncol 7: 1285-1288, 1995.
13. Alexiev BA: Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunochemical study using supersensitive monoclonal antibodies and the biotin-streptavin-amplified method. Diagn Cytopathol 15: 277-281, 1996.
14. Brown JR, Nigh E, Lee RJ, et al: Fos family members induce cell cycle entry by activating cyclin D1. Mol Cell Biol 18: 5609-5619, 1998. (Pubitemid 28388143)
15. Philips A, Teyssier C, Galtier F, Rivier-Covas C, Rey JM, Rochefort H and Chalbos D: Fra-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells. Mol Endocrinol 12: 973-985, 1998. (Pubitemid 30660665)
16. Bamberger AM, Methner C, Lisbos BW, Stadtler C, Schulte HM, Loning T and Milde-Langosch K: Expression pattern of the AP-1 family in breast cancer: association of fos B expression with a well-differentiated, receptor positive tumor phenotype. Int J Cancer 84: 533-538, 1999.
17. Kovary K and Bravo R: The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol 11: 4466-4472, 1991. (Pubitemid 21895842)
18. Nigro JM, Baker SJ, Preisinger AC, et al: Mutations in p53 gene occur in diverse human tumor types. Nature 342: 705-708, 1989. (Pubitemid 20001591)
19. Levine AJ, Momand J and Finlay CA: The p53 tumor suppressor gene. Nature 351: 453-456, 1991.
20. Callahan R: p53 mutations, another breast cancer prognostic factor. J Natl Cancer Inst 84: 826-827, 1992.
21. Bartek J, Bartkova J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J and Lane DP: Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int J Cancer 46: 839-844, 1990.
22. Lutz WK, Vamvakas S, Kopp-Schneider A, Schlatter J and Stopper H: Deviation from additivity in mixture toxicity: relevance of non-linear dose-response relationships and cell line differences in genotoxicity assays with combinations of chemical mutagens and gamma radiation. Environ Health Perspect 110: 915-918, 2002. (Pubitemid 36204282)
23. Knudson AG: Mutation and human cancer. Adv Cancer Res 17: 317-352, 1973.
24. Lee WH, Shew JY, Hong F, et al: The retinoblastoma susceptibility gene product is a nuclear phosphoprotein associated with DNA binding activity. Nature 329: 642-645, 1987. (Pubitemid 17140117)
25. Goodrich DW, Wang NP, Qian YW, Lee EY and Lee WH: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67: 293-302, 1991. (Pubitemid 121001445)
26. Calaf G and Hei TK: Establishment of a radiation and estrogen-induced breast cancer model. Carcinogenesis 21: 769-776, 2000. (Pubitemid 30214035)
27. Soule HD, Maloney TM, Wolman SR, et al: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line. MCF-10. Cancer Res 50: 6075-6086, 1990. (Pubitemid 20331424)
28. Calaf G, Russo J, Tait L. Estrada S and Alvarado ME: Morphological phenotypes in neoplastic progression of human breast epithelial cells. J Submicrosc Cytol Pathol 32: 83-96, 2000.
29. Calaf G, Russo J and Alvarado ME: Morphological phenotypes in neoplastic progression of benz(a)pyrene-treated breast epithelial cells. J Submicrosc Cytol Pathol 32: 535-545, 2001.
30. Wang Q, Lee D, Sysounthone V, Chandraratna R, Christakos S, Korah R and Wieder R: 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects. Breast Cancer Res Treat 67: 157-168, 2001. (Pubitemid 32744496)
31. Calaf G and Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492, 1993. (Pubitemid 23152785)
32. Calaf G and Hei TK: Oncoprotein expression in human breast epithelial cells transformed by high LET radiation. Int J Radiat Biol 77: 31-40, 2001. (Pubitemid 32096694)
33. Roy D, Calaf G and Hei TK: Profiling of differentially expressed genes induced by high-LET radiation in breast epithelial cells. Mol Carcinog 31: 192-203, 2001. (Pubitemid 32831345)
34. Roy D, Calaf G and Hei TK: Allelic imbalance at 11p15.5-15.4 correlated with c-Ha-ras mutation during radiation-induced neoplastic transformation human breast epithelial cells. Int J Cancer 103: 730-737, 2003. (Pubitemid 36110228)
35. Bonfil RD, Reddel RR, Ura H, Reich R, Fridman R, Harris CC and Klein-Szanto JP: Invasive and metastatic potential of a v-Haras transformed human bronchial epithelial cell line. J Natl Cancer Inst 81: 587-594, 1989. (Pubitemid 19104489)
36. Zhou M, Diwu Z, Panchuk-Voloshina and Haugland RP: A stable non-fluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253: 162-168, 1997. (Pubitemid 27508167)
37. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods 202: 113-141, 1997.
38. Xu A, Zhou H, Yu DZ and Hei TK: Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implications from mutation patterns induced by reactive oxygen species. Environ Health Perspect 110: 1003-1008, 2002. (Pubitemid 35175042)
39. Cabello G, Juarranz A, Botella LM and Calaf GM: Organo-phosphorous pesticides in breast cancer progression. J Submicrosc Cytol Pathol 35: 1-9, 2003. (Pubitemid 38658264)
40. Moriki T, Takahashi T, Tanioka F, Yamane T and Hara R: Proliferative activity in breast carcinoma evaluated by BrdU and PCNA. Correlation with the expression of p53, c-erbB-2, estrogen receptor and P-glycoprotein. Pathol Res Pract 11: 1122-1132, 1995. (Pubitemid 26031758)
41. Niewiadomska G, Jeziorski A and Olborski B: The expression of the proliferating antigen Ki67, PCNA and products of suppressor gene p53 in primary invasive ductal breast carcinoma. J Exp Clin Cancer Res 17: 503-510, 1998. (Pubitemid 29083427)
42. Lotan R: Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. Cancer Res 39: 1014-1019, 1979.
43. Wetherall NT, Reiss T, Parmenter M and Halter SA: Morphological effects of natural retinoids on human mammary carcinoma cell lines in monolayer culture. Scan Electron Microsc 4: 1565-1575, 1982.
44. Fraker LD, Halter SA and Forbes JT: Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. Cancer Res 44: 5757-5763, 1984. (Pubitemid 15183590)